Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Net Income | 91.93% | 51.11% | -284.98% | 64.17% | -9.79% |
| Total Depreciation and Amortization | -- | -186.37% | -15.12% | 245.58% | -0.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.73% | -111.94% | 37.27% | -794.77% | -6.77% |
| Change in Net Operating Assets | -- | -81.14% | 12.04% | 180.77% | -35.20% |
| Cash from Operations | 102.25% | -1,487.66% | -485.30% | 3,902.90% | -817.69% |
| Capital Expenditure | -- | -- | -- | -37,953.33% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -37,953.33% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 307.77% | -307.11% | -1,837.50% | -1,405.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -766.25% | 1,579.53% | 677.16% | 1,046.43% | 2,805.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -389.47% | 508.24% | -1,237.93% | 287.63% | 66.67% |